13F Holdings
中文EN

ODYY Odyssey Health, Inc.

Surgical & Medical Instruments & Apparatus · OTC · SEC CIK 1626644 · Fiscal year ends 07/31

Financial factors as of 2026-07-31 (2026Q4), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY-228.8%
TTM EPS YoY-150.0%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—

Returns

ROE—
ROA-5,799.8%
ROIC (approx.)—
Asset turnover—

Leverage & solvency

Liabilities / assets8,303.6%
Debt / equity—
Current ratio0.01x
Interest coverage-0.58x

Cash quality & payout

Operating cash flow / net income0.18x
Accruals ratio-4,740.6%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20262026-07-31FY20252025-07-31FY20242024-07-31FY20232023-07-31FY20222022-07-31
Income statement
Revenue—————
R&D expense$0$22,625$55,166$170,000—
SG&A expense$912,994$1.02M$2.08M$2.12M$2.92M
Operating income-$912,994-$1.02M-$2.14M-$5.31M-$8.11M
Interest expense$1.58M$252,516$518,476$614,083$836,294
Income tax$0$0$0$0$0
Net income-$5.73M-$1.74M-$842,316-$5.92M-$8.44M
EBITDA——-$2.14M-$5.31M-$8.10M
EPS (basic)-0.05-0.02-0.01-0.07-0.09
EPS (diluted)-0.05-0.02-0.01-0.07-0.09
Weighted avg. shares (diluted)108.32M104.71M97.06M82.68M89.00M
Balance sheet
Cash & equivalents$122,361$19,084$2,379$36,865$72,534
Current assets$147,859$49,723$56,943$405,888$526,417
PP&E, net————$0
Intangibles——$0$49,905$43,260
Total assets$147,859$49,723$586,146$455,793$569,677
Current liabilities$12.28M$7.00M$5.92M$6.61M$5.21M
Short-term debt————$1.18M
Total liabilities$12.28M$7.00M$5.92M$6.61M$5.21M
Shareholders' equity-$12.13M-$6.95M-$5.33M-$6.16M-$4.64M
Shares outstanding105.97M96.71M96.71M79.07M77.86M
Cash flow statement
Operating cash flow-$1.05M-$347,392-$1.22M-$1.47M-$1.47M
Investing cash flow$0$69,787$1.00M-$10,061—
Financing cash flow$1.15M$294,310$180,724$1.45M$1.45M
Depreciation & amortization——$1,538$3,416$3,416
Stock-based compensation$5,408$108,399$577,805$2.82M—

Free plan shows the latest 5 periods; Pro shows all 12 🔒

· This company does not report gross profit in XBRL.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.